Literature DB >> 20403066

Reexploring differences among for-profit and nonprofit dialysis providers.

Donald K K Lee1, Glenn M Chertow, Stefanos A Zenios.   

Abstract

OBJECTIVE: To determine whether profit status is associated with differences in hospital days per patient, an outcome that may also be influenced by provider financial goals. DATA SOURCES: United States Renal Data System Standard Analysis Files and Centers for Medicare and Medicaid Services cost reports.
DESIGN: We compared the number of hospital days per patient per year across for-profit and nonprofit dialysis facilities during 2003. To address possible referral bias in the assignment of patients to dialysis facilities, we used an instrumental variable regression method and adjusted for selected patient-specific factors, facility characteristics such as size and chain affiliation, as well as metrics of market competition. DATA EXTRACTION
METHODS: All patients who received in-center hemodialysis at any time in 2003 and for whom Medicare was the primary payer were included (N=170,130; roughly two-thirds of the U.S. hemodialysis population). Patients dialyzed at hospital-based facilities and patients with no dialysis facilities within 30 miles of their residence were excluded.
RESULTS: Overall, adjusted hospital days per patient were 17+/-5 percent lower in nonprofit facilities. The difference between nonprofit and for-profit facilities persisted with the correction for referral bias. There was no association between hospital days per patient per year and chain affiliation, but larger facilities had inferior outcomes (facilities with 73 or more patients had a 14+/-1.7 percent increase in hospital days relative to facilities with 35 or fewer patients). Differences in outcomes among for-profit and nonprofit facilities translated to 1,600 patient-years in hospital that could be averted each year if the hospital utilization rates in for-profit facilities were to decrease to the level of their nonprofit counterparts.
CONCLUSIONS: Hospital days per patient-year were statistically and clinically significantly lower among nonprofit dialysis providers. These findings suggest that the indirect incentives in Medicare's current payment system may provide insufficient incentive for for-profit providers to achieve optimal patient outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20403066      PMCID: PMC2875752          DOI: 10.1111/j.1475-6773.2010.01103.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  12 in total

1.  Ownership of dialysis facilities and patients' survival.

Authors:  F K Port; R A Wolfe; P J Held
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

2.  How to make a silk purse from a sow's ear--a comprehensive review of strategies to optimise data for corrupt managers and incompetent clinicians.

Authors:  David Pitches; Amanda Burls; Anne Fry-Smith
Journal:  BMJ       Date:  2003-12-20

3.  How nonprofits matter in American medicine, and what to do about it.

Authors:  Mark Schlesinger; Bradford H Gray
Journal:  Health Aff (Millwood)       Date:  2006-06-20       Impact factor: 6.301

4.  Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.

Authors:  P P Garg; K D Frick; M Diener-West; N R Powe
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

5.  Quality of care differences by ownership in United States renal dialysis facilities.

Authors:  R A Irvin
Journal:  ASAIO J       Date:  2000 Nov-Dec       Impact factor: 2.872

6.  Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients.

Authors:  D L Frankenfield; J R Sugarman; R J Presley; S D Helgerson; M V Rocco
Journal:  Am J Kidney Dis       Date:  2000-08       Impact factor: 8.860

7.  Quality of care in investor-owned vs not-for-profit HMOs.

Authors:  D U Himmelstein; S Woolhandler; I Hellander; S M Wolfe
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

8.  Assessments of medical care by enrollees in for-profit and nonprofit health maintenance organizations.

Authors:  Ha T Tu; James D Reschovsky
Journal:  N Engl J Med       Date:  2002-04-25       Impact factor: 91.245

9.  Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.

Authors:  Mae Thamer; Yi Zhang; James Kaufman; Dennis Cotter; Fan Dong; Miguel A Hernán
Journal:  JAMA       Date:  2007-04-18       Impact factor: 56.272

10.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Authors:  M McClellan; B J McNeil; J P Newhouse
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

View more
  19 in total

1.  Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care.

Authors:  Hua Hao; Brendan P Lovasik; Stephen O Pastan; Howard H Chang; Ritam Chowdhury; Rachel E Patzer
Journal:  Kidney Int       Date:  2015-04-22       Impact factor: 10.612

2.  Health Policy for Dialysis Care in Canada and the United States.

Authors:  Marcello Tonelli; Raymond Vanholder; Jonathan Himmelfarb
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 8.237

3.  For-profit status and industry evolution in health care markets: evidence from the dialysis industry.

Authors:  Nathan E Wilson
Journal:  Int J Health Econ Manag       Date:  2016-07-14

4.  Use of instrumental variables for endogenous treatment at the provider level.

Authors:  R Tamara Konetzka; Fan Yang; Rachel M Werner
Journal:  Health Econ       Date:  2019-01-22       Impact factor: 3.046

5.  Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.

Authors:  Theresa I Shireman; Jonathan D Mahnken; Milind A Phadnis; Edward F Ellerbeck; James B Wetmore
Journal:  Kidney Blood Press Res       Date:  2016-11-21       Impact factor: 2.687

6.  Safety-Net Care for Maintenance Dialysis in the United States.

Authors:  Kevin F Erickson; Jenny I Shen; Bo Zhao; Wolfgang C Winkelmayer; Glenn M Chertow; Vivian Ho; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2019-12-19       Impact factor: 10.121

7.  Market Competition and Health Outcomes in Hemodialysis.

Authors:  Kevin F Erickson; Yuanchao Zheng; Vivian Ho; Wolfgang C Winkelmayer; Jay Bhattacharya; Glenn M Chertow
Journal:  Health Serv Res       Date:  2018-02-22       Impact factor: 3.402

8.  For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.

Authors:  Sounok Sen; Pamela R Soulos; Jeph Herrin; Kenneth B Roberts; James B Yu; Beth-Ann Lesnikoski; Joseph S Ross; Harlan M Krumholz; Cary P Gross
Journal:  Surgery       Date:  2013-12-15       Impact factor: 3.982

9.  Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition.

Authors:  Kevin F Erickson; Yuanchao Zheng; Wolfgang C Winkelmayer; Vivian Ho; Jay Bhattacharya; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

10.  Patient care staffing levels and facility characteristics in U.S. hemodialysis facilities.

Authors:  Laura A G Yoder; Wenjun Xin; Keith C Norris; Guofen Yan
Journal:  Am J Kidney Dis       Date:  2013-06-28       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.